A landmark examine that discovered the blockbuster weight problems drug Wegovy reduces the prospect of coronary heart issues provides urgency to a fundamental query in drugs: what precisely is the connection between weight and well being?
On its face, the consequence that Wegovy lower the chance of main cardiovascular problems by 20% lends credence to arguments by drugmakers, together with Wegovy producer Novo Nordisk, that weight problems is a illness and weight reduction makes individuals more healthy.
However researchers and docs cautioned that the outcomes don’t show weight problems remedies enhance coronary heart well being solely by serving to individuals reduce weight. It’s probably that weight reduction is one trigger, they stated, however there might be different key mechanisms at play impartial from Wegovy’s impact on physique weight.